Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway

Class:IdLiteratureReference:199857
_displayNameIdentification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway
_timestamp2007-07-12 14:42:53
author[Person:199822] Manning, BD
[Person:199852] Tee, AR
[Person:199853] Logsdon, MN
[Person:141134] Blenis, J
[Person:140008] Cantley, Lewis C
created[InstanceEdit:199866] Jassal, B, 2007-07-12 14:41:47
journalMol Cell
pages151-62
pubMedIdentifier12150915
titleIdentification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway
volume10
year2002
(literatureReference)[Reaction:198609] AKT phosphorylates TSC2, inhibiting it [Homo sapiens]
[Reaction:2399982] AKT1 E17K mutant phosphorylates TSC2, inhibiting it [Homo sapiens]
[Summation:2399980] AKT1 E17K gain-of-function mutant is expected to phosphoryla...
[Change default viewing format]
No pathways have been reviewed or authored by Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway (199857)